Key result
Statins show no effect on major depression or depressive symptom severity in low-bias RCTs.
Why the study?
Statins have been proposed for repurposing in depression, but previous meta-analyses reported heterogeneous results and seldom addressed suicidality.
Does statin treatment reduce the risk of depression, depressive symptom severity, and suicidality in predominantly adult populations?
Systematic Review
Does statin treatment reduce the risk of depression, depressive symptom severity, and suicidality in predominantly adult populations?
This systematic review of 60 studies demonstrates that while statins do not worsen mood or consistently increase suicidality, high-quality RCT and large-cohort evidence does not support prescribing statins for antidepressant or suicide-preventive purposes.
Answers are grounded in this paper and cite their sources.
No support for statin repurposing in depression or suicidality; challenges small positive trials with null large-RCT results.
Statins have been proposed for repurposing in depression, but previous meta-analyses reported heterogeneous results and seldom addressed suicidality. We systematically reviewed the association of statin treatment with the risk of depression, depressive symptom severity and suicidality. We searched 3 databases (Embase, PsycINFO and PubMed) up to 31 March 2026 for observational and interventional studies in predominantly adult populations, published in English or French. Risk of bias and methodological quality were assessed with RoB 2 for randomised controlled trials (RCTs) and the NIH/NHLBI tools for observational studies. Results were synthesised by design, outcome and sample size. Sixty studies were included (9 cross-sectional, 38 longitudinal and 13 RCTs; 20 to over 4.6 million participants), 55 assessing depression and 11 suicidality. Observational associations were heterogeneous: generally modest in large general-population studies, mainly inverse in disease-specific populations, but discordant after stroke and traumatic brain injury. Larger antidepressant effects of adjunctive statins were reported in small single-centre RCTs. In contrast, the two largest trials in major depressive disorder, both at low risk of bias, yielded estimates close to zero. No consistent association with suicidality was observed, and no trial showed a significant worsening of mood. This systematic review updates and extends previous meta-analyses on statins. Observational results were heterogeneous. Lower suicide mortality was observed in two cohorts, but the largest study found no association with suicidal behaviour. Larger antidepressant effects were confined to small single-centre trials. Current evidence therefore does not support prescribing statins for antidepressant or suicide-preventive purposes.
No takes yet. Share an insight, caveat, or question.
Silva1 et al. (2026) conducted a systematic review in Depression and suicidality. Statin treatment vs. Placebo or no statin treatment was evaluated on Risk of depression, depressive symptom severity, and suicidality (suicidal ideation, suicide attempts, and suicide deaths). Statin treatment showed heterogeneous observational associations with depression and suicidality, while the largest low-bias RCTs in major depression found near-zero effects.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: